139 related articles for article (PubMed ID: 5603840)
1. [On the use of 2-beta-hydroxyphenetylaminopyridine 1-(p-hydroxyphenyl)-2-phenyl-3-hydroxy-4-n-butyl-5-pyrazolinonate in venous and arterial vasculopathies].
Gazzaniga M; Aulisa B; Maconi F
Minerva Cardioangiol; 1967 Mar; 15(5):343-52. PubMed ID: 5603840
[No Abstract] [Full Text] [Related]
2. [Use of the 1(p-hydroxyphenyl)-2-phenyl-3-hydroxy-4-n-butyl-5-pyrazolinonate of 2-beta-hydroxyphenethylaminopyridine in venous and arterial vascular diseases].
Gazzaniga M; Aulisa B; Maconi F
Minerva Med; 1967 Apr; 58(32):1439-48. PubMed ID: 6029507
[No Abstract] [Full Text] [Related]
3. Preliminary results in the treatment of peripheral arteriopathies with a new pharmacologic substance: I-(2"pyrimidyl)4 piperonyl piperazine (ET 495).
Royer RJ
Bibl Cardiol; 1969; 26():174-9. PubMed ID: 5402343
[No Abstract] [Full Text] [Related]
4. [The use of nicotinyl alcohol in delayed-action form in some obstetrical gynecological vascular diseases].
De Marini M
Minerva Ginecol; 1969 Jan; 21(2):63-6. PubMed ID: 5776754
[No Abstract] [Full Text] [Related]
5. [Application of bencyclane in arterial insufficiency of the lower limbs].
Krylov VS; Zuravlev IV; Djacenko GM; Vychovskaja AA
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1433+. PubMed ID: 5536664
[No Abstract] [Full Text] [Related]
6. [Prolonged intravenous and intra-arterial administration of large doses of Raubasine in peripheral arterial diseases].
Raso AM; Silvestrini P
Minerva Med; 1973 Mar; 64(19):961-9. PubMed ID: 4703313
[No Abstract] [Full Text] [Related]
7. Arterial disorders of the extremities: clinical syndromes; assessment and measurement.
Abramson DI
Arch Phys Med Rehabil; 1968 Jun; 49(6):315-25. PubMed ID: 5667243
[No Abstract] [Full Text] [Related]
8. [New data on the use of halidor in obliterative diseases of arteries of the extremities].
Zolotarevskiĭ VIa; Taranovich VA; Maksimova TV
Klin Med (Mosk); 1969 Feb; 47(2):67-71. PubMed ID: 5379263
[No Abstract] [Full Text] [Related]
9. [Treatment of arteriopathies of limbs by xanthinol nicotinate].
Elbaz C
Phlebologie; 1969; 22(1):105-11. PubMed ID: 5775643
[No Abstract] [Full Text] [Related]
10. [Results of treating obliterative diseases of the peripheral arteries with intra-arterial administrations of acetylcholine].
Stepanova-Nikitina GG; Rage KM
Sov Med; 1970; 33(8):45-9. PubMed ID: 5490077
[No Abstract] [Full Text] [Related]
11. Experiences with thermography in peripheral vascular disease.
Heerma van Voss SF
Acta Chir Belg; 1968 May; 67(5):457-64. PubMed ID: 5742393
[No Abstract] [Full Text] [Related]
12. Experiences with thermography in peripheral vascular disease.
van Voss H
Acta Chir Belg; 1968 May; 67(5):457-64. PubMed ID: 5711962
[No Abstract] [Full Text] [Related]
13. [A new anti-inflammatory agent in angiology: benzydamine hydrochloride].
Merlen JF; Coget J
Phlebologie; 1971; 24(3):281-5. PubMed ID: 5123780
[No Abstract] [Full Text] [Related]
14. [Clinical experience with bencyclane in the treatment of vascular obliterations in the limbs].
Krakovskij NI; Taranovic VA
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1435+. PubMed ID: 5536665
[No Abstract] [Full Text] [Related]
15. Treating principles and methods of traditional Chinese medicine in treatment of peripheral vascular diseases.
Zhang Y; Chen Z; Liu Y; Zhang Y
J Tradit Chin Med; 2001 Jun; 21(2):130-3. PubMed ID: 11498903
[No Abstract] [Full Text] [Related]
16. [The use of mydocalm in the treatment of vascular diseases of the extremities].
Liubishchev SA
Klin Med (Mosk); 1967 Jan; 45(1):100-2. PubMed ID: 5613382
[No Abstract] [Full Text] [Related]
17. [Rheographic study of the activity of some vasoactive drugs on peripheral arterial circulation].
Capitanucci P; Martinelli M; De Gregorio M
Minerva Cardioangiol; 1968 Nov; 16(11):1074-82. PubMed ID: 5707452
[No Abstract] [Full Text] [Related]
18. Vascular disorders in leg arteries, approached by means of thermography.
Buwalda G
Bibl Radiol; 1969; 5():121-6. PubMed ID: 5762015
[No Abstract] [Full Text] [Related]
19. [Effect of bencyclane in obliterative arterial diseases].
Kusztos D
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
[No Abstract] [Full Text] [Related]
20. [Clinical use of thymoxamine in peripheral arterial pathology].
Ghiglino GC; Viacava A; Gori A; Misuri A; Lucertini G; Pelagatti M
Clin Ter; 1983 Apr; 105(2):103-7. PubMed ID: 6222862
[No Abstract] [Full Text] [Related]
[Next] [New Search]
